Access our review in  Journal of Translational Science via
https://www.oatext.com/pdf/JTS-6-356.pdf

Journal of Translational Science

 

A review of GOLPH2, an oncogenic protein

and novel therapeutic options for GOLPH2 driven tumors

Yang Liu, Heike Liewen, Norbert Markuly and Frank Stenner

Witterswil and Basel, Switzerland

Access our publication in Targeted Oncology via
https://doi.org/10.1007/s11523-019-00667-z


European Antibody Congress 2019

Egotumab, a human  antibody targeting GOLPH2 in colorectal cancer was presented at the European Antibody Congress 2019 in Basel, Switzerland.


3rd Annual Next Gen Immune-Oncology Congress 2019
Egotumab, a human antibody against colorectal cancer, was presented at the Poster Session on 15.03.2019 in London, UK.


European Antibody Congress 2018

Egotumab, a human antibody against colorectal cancer, was presented in a keynote lecture on Wednesday 31.10.2018 in Basel, Switzerland.


BaseLaunch selected CUREAB for phase I of its accelerator program in 2018